NEW YORK (GenomeWeb) – Becton Dickinson said today that it has entered into a $9.1 bridge loan agreement to ensure that it will be able to fund its $12.2 billion acquisition of CareFusion.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Nature News reports that researchers in Japan hope to soon test the use of reprogrammed stem cells to treat damaged corneas.
A new approach may help limit the number of fish that are mislabeled at markets or restaurants, according to New Scientist.
At Slate, the R Street Institute's Nila Bala discusses the privacy rights of suspects that genetic genealogy approaches in law enforcement bring up.
In PNAS this week: numerous mobile genetic elements contribute to Vibrio cholerae drug resistance, troponin I mutations in sudden infant deaths, and more.